Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
- Conditions
- Essential Tremor
- Registration Number
- NCT04032470
- Lead Sponsor
- Boston Scientific Corporation
- Brief Summary
To compile characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Deep Brain Stimulation (DBS) Systems, when used according to the applicable Directions for Use, for the treatment of Essential Tremor.
- Detailed Description
To compile characteristics of real-world outcomes using Deep Brain Stimulation (DBS) for the treatment of Essential Tremor to add to the evidence available for treatment of ET.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Meets criteria established in the locally applicable Directions for Use (DFU) for Essential Tremor
- Is at least 18 years old
- Meets any contraindication in locally applicable Directions for Use
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Quality of Life during the study as compared with baseline using the Quality of Life in Essential Tremor Questionnaire (QUEST) Up to 3 years Change in quality of life over the course of the study using QUEST
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (20)
A.o. LKH Univ.-Kliniken Innsbruck
🇦🇹Innsbruck, Austria
AZ Sint-Lucas
🇧🇪Ghent, Belgium
UZ Gasthuisberg
🇧🇪Leuven, Belgium
AZ Delta
🇧🇪Roeselare, Belgium
Vancouver General Hospital
🇨🇦Vancouver, Canada
Uniklinik Koln
🇩🇪Cologne, Germany
Universitaetsklinikum Dusseldorf
🇩🇪Düsseldorf, Germany
Universitaetsklinikum Essen
🇩🇪Essen, Germany
Universitatsklinikum Campus Kiel
🇩🇪Kiel, Germany
Universitaetsklinikum Giessen und Marburg GmbH
🇩🇪Marburg, Germany
Scroll for more (10 remaining)A.o. LKH Univ.-Kliniken Innsbruck🇦🇹Innsbruck, AustriaBoston Scientific Clinical ResearchContact855-213-9890BSNClinicalTrials@bsci.com